Disease / condition

Bronchopulmonary Dysplasia clinical trials

Free access to 94 studies·10+ countries·Updated daily19 recruiting
94
Total trials
10+
Countries
10+
Sponsors
19
Recruiting
By phase
N/A44
Phase 115
Phase 213
Phase 38
Early Phase 15
By status
Completed32
Recruiting19
Unknown16
Not yet recruit...14
Withdrawn5
Top countries
United States of America22
China18
Canada7
France5
South Korea5
Top sponsors
Children's Hospita...6
Medipost Co Ltd.4
Boston Children's ...3
Children's Hospita...3
Wang Jianhui3
Recent trials
Latest clinical trials for Bronchopulmonary Dysplasia
NCT06421519·Phase 1/2Recruiting
Different Levels of BiPAP
King's College Hospital NHS Tr...United Kingdom
NCT06342752Not yet recr...
The Role of VOCs, Airway Mucins and Airway Microbiome in Bronchopulmonary Dysplasia
University Hospital, Antwerp
NCT06279741·Phase 1/2Recruiting
Safety and Efficacy of MSC-EVs in the Prevention of BPD in Extremely Preterm Infants
EXO Biologics S.A.Belgium,Italy
NCT06270199·Phase 2Recruiting
Use of Mesenchymal Stem Cells in Pre-term Patients With Bronchopulmonary Dysplasia.
Fundacion para la Investigacio...Spain
NCT05925075Enrolling by...
Lung Ultrasound in Preterm Infants
Phoenix Children's HospitalUnited States of America
NCT05898022·Phase 4Not yet recr...
Pragmatic Research on Diuretic Management in Early BPD Pilot
Children's Hospital Medical Ce...United States of America
NCT05777512Not yet recr...
Randomized Controlled Crossover Trial of Postpyloric Feedings to Improve Pulmonary Outcomes in High-risk Preterm Infants
Boston Children's Hospital
NCT05682807·Phase 3Recruiting
Effect of Caffeine Versus Probiotic on Preterm Neonates With Bronchopulmonary Dysplasia
Tanta UniversityEgypt
NCT05285345Not yet recr...
Implementation of a Consensus-Based Discharge Protocol for Preterm Infants With Lung Disease
Boston Children's Hospital
NCT05181319Recruiting
Prediction for Bronchopulmonary Dysplasia
Kai MuChina
NCT05055193Completed
Outcome of Extremely Preterm Infants Who Received Systemic Postnatal Corticosteroid for Bronchopulmonary Dysplasia
Hospices Civils de LyonFrance
NCT04936477Not yet recr...
Ventilation-perfusion (V/Q) Ratio and Alveolar Surface Area in Preterm Infants
King's College LondonUnited Kingdom
ChiCTR2100047116Not yet recr...
Untitled Trial
Children's Hospital of Chongqi...China
NCT04941963Recruiting
Ultrasound Assessment of Diaphragmatic Function in Infants With BPD
Mount Sinai Hospital, CanadaCanada
NCT04785859Recruiting
Multiparametric Bronchopulmonary Prediction
Andaluz Health ServiceSpain
NCT04662151·Phase 1Not yet recr...
Phase 1b Study on AT-100 Intervention (rhSP-D) in Preterm Neonates at High Risk for Development of Bronchopulmonary Dysplasia (BPD)
Airway Therapeutics, Inc.
NCT04619602·Phase 1Not yet recr...
Inhaled Treatment for Bronchopulmonary Dysplasia
University Hospitals Cleveland...United States of America
NCT04560179·Phase 1Not yet recr...
Inhaled Tobramycin in BPD
Erik Allen Jensen
NCT04555889Not yet recr...
The Impact of Lung Recruitment Maneuver in 24-32 Weekers, and the Incidence of Bronchopulmonary Dysplasia
Dr. R. Adhi Teguh Perma Iskand...
ChiCTR2000035227·Early Phase 1Completed
Untitled Trial
The Seventh Medical Center of ...China
About this record

Access comprehensive clinical trial information for Bronchopulmonary Dysplasia through Pure Global AI's free database. This collection includes 94 clinical trials across multiple phases including N/A, Phase 1, Phase 2. Currently, 19 trials are actively recruiting participants.

Research for Bronchopulmonary Dysplasia is being conducted in United States of America, China, Canada and 7+ other countries. Leading sponsors include Children's Hospital of Chongqing Medical University and Medipost Co Ltd.. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.

Pure Global AI provides free access to 94 clinical trials studying Bronchopulmonary Dysplasia, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.

The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.

Top research sponsors include Children's Hospital of Chongqing Medical University, Medipost Co Ltd., Boston Children's Hospital, among others.